Please assess the completion status of the following clinical trial:

Trial Title: Extended-release Naltrexone for Alcohol Dependence in Primary Care

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Current alcohol dependence~* Age 18 or older~* English or Spanish-speaking~* Without untreated severe mental illness~* Liver enzymes (alanine aminotransferase and aspartate aminotransferase) ≤ 3x normal~* Kept 2 of last 3 clinic primary care appointments and/or has a working telephone number at which can be contacted directly~* Either a) currently abstinent (e.g., referred from an inpatient 'detox' setting) or b) with the ability, in the clinician's judgment, to achieve and maintain abstinence~* If female of child-bearing potential, must be using adequate contraception~* Able to understand study procedures~Exclusion Criteria:~* Currently opioid dependent or requiring ongoing treatment with opioids for any indication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Extended release injectable naltrexone (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).